An Open Label Safety Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain.

Trial Profile

An Open Label Safety Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 May 2017

At a glance

  • Drugs Oxycodone/paracetamol (Primary)
  • Indications Back pain; Osteoarthritis
  • Focus Adverse reactions; Registrational
  • Sponsors Mallinckrodt LLC
  • Most Recent Events

    • 03 May 2014 Tolerability results from a pooled analysis of two phase III trials presented at the 33rd Annual Scientific Meeting of the American Pain Society.
    • 29 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Feb 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top